NCT06215209

Brief Summary

Acute respiratory distress syndrome (ARDS) is a heterogeneous syndrome with similar clinicopathological feathers caused by different etiologies. Respiratory supportive strategies is the main ARDS management, and the guidelines recommend low tidal volume to improve clinical outcomes. To be note, overdistension can still occur even if using a tidal volume as low as 6 ml/kg, given the heterogeneous nature of the syndrome. Therefore, adjusting tidal volume level to less than 6ml/kg may reduce ventilator-induced lung injury (VILI) and thus improve outcomes, especially in patients with severe lung injury. Prone position is also an important management in severe ARDS. Prone position can improve ventilation-perfusion (V/Q) matching and reduce the risk of VILI by recruiting dorsal collapsed alveoli. Meanwhile, prone position has also been shown to improve hemodynamics. Recent studies have showed that prone position did not reduce duration of venovenous extracorporeal membrane oxygenation (VV-ECMO) and 90-day mortality in patients with ARDS who receive VV-ECMO with ultra-low tidal volume ventilation. Therefore, the effect of PP on ventilation and lung blood flow in ARDS patients treated with VV-ECMO wiht ultra-low tidal volume ventilation remains unclear.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 10, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 22, 2024

Completed
29 days until next milestone

Study Start

First participant enrolled

February 20, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
Last Updated

April 30, 2024

Status Verified

April 1, 2024

Enrollment Period

12 months

First QC Date

January 10, 2024

Last Update Submit

April 28, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • ventilation-perfusion mathching

    ventilation-perfusion matching will be monitored using an EIT monitor (PulmoVista® 500, Dräger, Lübeck, Germany) in supine position and prone position

    up to 24 hours

Secondary Outcomes (8)

  • The percentage of shunt

    up to 24 hours

  • The percentage of dead space

    up to 24 hours

  • The percentage of dorsal ventilation

    up to 24 hours

  • The percentage of dorsal perfusion

    up to 24 hours

  • Center of ventilation (CoV)

    up to 24 hours

  • +3 more secondary outcomes

Study Arms (1)

ultra-low tidal volume group

ARDS patients with ultra-low tidal volume ventilation

Other: position

Interventions

patients will be in supine position and prone position

ultra-low tidal volume group

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients with ARDS admitted to the Department of Critical Care Medicine, Zhongda Hospital, Southeast University and receiving VV-ECMO treatment

You may qualify if:

  • Adult patients were enrolled if they were undergoing invasive mechanical ventilation and were supported by VV-ECMO for less than 48 hours

You may not qualify if:

  • younger than 18 years old
  • contraindications for prone position ventilation
  • past chronic respiratory diseases (long-term family oxygen therapy for chronic
  • respiratory diseases such as pulmonary fibrosis or COPD)
  • New York Heart Association class above II
  • contraindications to the use of EIT (e.g., presence of pacemaker or chest surgical wounds dressing) or prone position (as decided by the attending physician)
  • severe hemodynamic instability
  • gave written or witnessed verbal informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University

Nanjing, Jiangsu, 210000, China

RECRUITING

MeSH Terms

Conditions

Respiratory Distress Syndrome

Interventions

Patient Positioning

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Intervention Hierarchy (Ancestors)

Patient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • liu ling, phD

    Zhongda Hospital

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Intensive Care Unit, Principal Investigator, Clinical Professor

Study Record Dates

First Submitted

January 10, 2024

First Posted

January 22, 2024

Study Start

February 20, 2024

Primary Completion

February 1, 2025

Study Completion

April 1, 2025

Last Updated

April 30, 2024

Record last verified: 2024-04

Locations